10x Genomics, Inc. TXG Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s other accrued liabilities?
- 10x Genomics, Inc. (TXG) reported other accrued liabilities of $8.44M in Q1 2026.
- How has 10x Genomics, Inc.'s other accrued liabilities changed year-over-year?
- 10x Genomics, Inc.'s other accrued liabilities decreased by 31.4% year-over-year, from $12.3M to $8.44M.
- What is the long-term trend for 10x Genomics, Inc.'s other accrued liabilities?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s other accrued liabilities has grown at a 13.5% compound annual growth rate (CAGR), from $5.84M to $11M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.